Clinical Data AAN 2026: J&J, Kyverna, Capricor and Praxis showcase practice-changing data BioSpaceThis year's American Academy of Neurology meeting included a presentation that could one day set a new treatment standard for myasthenia gravis.Clinical DataNeuroscienceRead full story pharminent April 23, 2026 (Last updated: April 23, 2026) BioSpace This year’s American Academy of Neurology meeting included a presentation that could one day set a new treatment standard for myasthenia gravis. Clinical DataNeuroscienceRead full story Post navigation Previous: Minnesota’s 340B Hospitals Make One Billion More From 340B Than They Spend on Uncompensated CareNext: Roche insists amylin obesity drug still valuable for patients who ‘don’t want side effects’ Related Stories Clinical Data Novo Nordisk starts trialing lower maintenance doses of oral Wegovy pharminent August 21, 2026 Clinical Data Cancer vaccine win restores Wall Street’s faith in Moderna pharminent August 20, 2026 Clinical Data New Taiho, Cullian data heats up lung cancer drug battle pharminent August 13, 2026
